CRISPR clinal trials Meletios Verras/iStock/Getty Images Plus By Science News January 20, 2019 at 2:09 pm The gene editor CRISPR/Cas9 (illustrated) enters its first clinical trials, to combat cancer, blindness and blood disorders in people.
